Early angiotensin converting enzyme inhibitor therapy after experimental myocardial infarction prevents left ventricular dilation by reducing infarct expansion: a possible mechanism of clinical benefits

被引:8
作者
Ali, SM [1 ]
Brown, EJ [1 ]
Nallapati, SR [1 ]
Alhaddad, IA [1 ]
机构
[1] Bronx Lebanon Hosp Ctr, Dept Med, Div Cardiol, Bronx, NY 10457 USA
关键词
myocardial infarction; infarct expansion; left ventricular remodeling; left ventricular dilation;
D O I
10.1097/00019501-199809120-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To examine the effects of early angiotensin-converting enzyme (ACE) inhibitor therapy after myocardial infarction on infarct expansion in an experimental rat model. Background ACE inhibitor therapy within 24 h of acute myocardial infarction (AMI) reduces mortality by unknown mechanism(s). Methods Rats underwent permanent coronary artery occlusion. A treated group received enalapril (1.9 +/- 0.2 mg/kg) daily in drinking water beginning 2 h after coronary artery occlusion, a time too late to reduce infarct size. Rats were sacrificed 2 days or 2 weeks after myocardial infarction. Hearts were arrested and fixed at a constant pressure, then sectioned and photographed for morphometric analysis. Results Infarcts in the control group expanded between 2 days and 2 weeks after myocardial infarction (expansion index 0.7 +/- 0.1 versus 2.5 +/- 0.4, P < 0.05). However, infarct expansion remained unchanged in the enalapril group between 2 days and 2 weeks after myocardial infarction (expansion index 0.8 +/- 0.1 versus 1.3 +/- 0.1, NS). Two weeks after myocardial infarction, the enalapril group had fewer expanded infarcts than the control group (expansion index 1.3 +/- 0.1 versus 2.5 +/- 0.4, P < 0.05). While left ventricular volume increased in the control group between 2 days and 2 weeks after myocardial infarction (0.17 +/- 0.01 ml versus 0.36 +/- 0.03 ml, P < 0.05), it remained constant in the enalapril group (0.22 +/- 0.02 ml versus 0.25 +/- 0.03 ml, NS). Two weeks after myocardial infarction, the left ventricles were larger in the control group than in the enalapril group (0.36 +/- 0.03 ml versus 0.25 +/- 0.03 ml, P < 0.05). Conclusions Treatment with enalapril initiated 2 h after AMI prevented left ventricular dilation by limiting infarct expansion. This may explain the mechanism by which ACE inhibitor therapy started within 24 h of an AMI improves survival 5-6 weeks after infarction. Coronary Artery Dis 9:815-821 (C) 1998 Lippincott Williams & Wilkins.
引用
收藏
页码:815 / 821
页数:7
相关论文
共 35 条
[1]   Benefits of late coronary artery reperfusion on infarct expansion progressively diminish over time: Relation to viable islets of myocytes within the scar [J].
Alhaddad, IA ;
Kloner, RA ;
Hakim, I ;
Garno, JL ;
Brown, EJ .
AMERICAN HEART JOURNAL, 1996, 131 (03) :451-457
[2]   ASPIRIN ENHANCES THE BENEFITS OF LATE REPERFUSION ON INFARCT SHAPE - A POSSIBLE MECHANISM OF THE BENEFICIAL-EFFECTS OF ASPIRIN ON SURVIVAL AFTER ACUTE MYOCARDIAL-INFARCTION [J].
ALHADDAD, IA ;
TKACZEVSKI, L ;
SIDDIQUI, F ;
MIR, R ;
BROWN, EJ .
CIRCULATION, 1995, 91 (11) :2819-2823
[3]   THE EFFECT OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR ZOFENOPRIL ON MORTALITY AND MORBIDITY AFTER ANTERIOR MYOCARDIAL-INFARCTION [J].
AMBROSIONI, E ;
BORGHI, C ;
MAGNANI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (02) :80-85
[4]  
[Anonymous], 1988, LANCET, V2, P349
[5]   NONINVASIVE ASSESSMENT OF VENTRICULAR DAMAGE IN RATS WITH MYOCARDIAL-INFARCTION [J].
BAILY, RG ;
LEHMAN, JC ;
GUBIN, SS ;
MUSCH, TI .
CARDIOVASCULAR RESEARCH, 1993, 27 (05) :851-855
[6]  
BALL SG, 1993, LANCET, V342, P821
[7]   ACUTE EFFECTS OF DELAYED REPERFUSION ON MYOCARDIAL INFARCT SHAPE AND LEFT-VENTRICULAR VOLUME - A POTENTIAL MECHANISM OF ADDITIONAL BENEFITS FROM THROMBOLYTIC THERAPY [J].
BROWN, EJ ;
SWINFORD, RD ;
GADDE, P ;
LILLIS, O .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 17 (07) :1641-1650
[8]   Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in the rat [J].
Burrell, LM ;
Chan, R ;
Phillips, PA ;
Calafiore, P ;
Tonkin, AM ;
Johnston, CI .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1996, 23 (6-7) :570-572
[9]   CAPTOPRIL IN ACUTE MYOCARDIAL-INFARCTION - BENEFICIAL-EFFECTS ON INFARCT SIZE AND ARRHYTHMIAS [J].
BUSSMANN, WD ;
MICKE, G ;
HILDENBRAND, R ;
KLEPZIG, H .
CLINICAL CARDIOLOGY, 1995, 18 (08) :465-470
[10]  
COLLINS R, 1995, LANCET, V345, P669